Hence, by inhibiting AR and SD enzymes, and preventing the formation of AGEs, it is possible to mitigate the risk of cataract development, diabetic retinopathy, and other microvascular problems associated with diabetes (Homme et al., 2018). Here, AR is linked to diabetic retinopathy.